1. Home
  2. SER vs IXHL Comparison

SER vs IXHL Comparison

Compare SER & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$3.14

Market Cap

42.0M

Sector

Health Care

ML Signal

HOLD

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$0.41

Market Cap

49.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SER
IXHL
Founded
2017
2001
Country
United States
Australia
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.0M
49.1M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
SER
IXHL
Price
$3.14
$0.41
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$13.00
N/A
AVG Volume (30 Days)
15.1K
24.4M
Earning Date
11-13-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$116,000.00
$12,000.00
Revenue This Year
$134.46
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.15
$0.08
52 Week High
$7.92
$2.25

Technical Indicators

Market Signals
Indicator
SER
IXHL
Relative Strength Index (RSI) 31.13 53.22
Support Level $3.15 $0.38
Resistance Level $4.26 $0.50
Average True Range (ATR) 0.25 0.04
MACD -0.03 0.01
Stochastic Oscillator 4.50 54.35

Price Performance

Historical Comparison
SER
IXHL

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: